Viaskin

Aimmune Therapeutics Inc (NASDAQ: AIMT) shares, which recovered Monday following an earnings-induced sell-off Friday, are adding to the gains.  The Aimmune Catalyst: Shares of Brisbane, California-based Aimmune — which has a commercial product in Palforzia, used to treat peanut allergy...

Shares of biopharma Aimmune Therapeutics Inc (NASDAQ: AIMT) advanced strongly in after-hours trading Friday following a positive FDA verdict for Aimunne's peanut allergy drug. 9-Year Wait Ends The FDA approved Palforzia allergen powder for treating patients with confirmed diagnosis of...